These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1160229)

  • 1. Heparin therapy in anti-basement membrane nephritis.
    Bone JM; Valdes AJ; Germuth FG; Lubowitz H
    Kidney Int; 1975 Aug; 8(2):72-9. PubMed ID: 1160229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of heparin to affect two types of experimental glomerulonephritis in rabbits.
    Border WA; Wilson CB; Dixon FJ
    Kidney Int; 1975 Sep; 8(3):140-8. PubMed ID: 126330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of fibrinogen in renal disease. 3. Fibrinolytic and anticoagulant treatment of nephrotoxic serum nephritis in mice.
    Briggs JD; Kwaan HC; Potter EV
    J Lab Clin Med; 1969 Nov; 74(5):715-24. PubMed ID: 4186944
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of the administration of heparin on the urinary excretion of fibrinogen-like antigens in glomerular nephropathies].
    L'Abbate A; Ciccarelli C; Poggi A; Maggiore Q
    Minerva Nefrol; 1974; 21(3):141-6. PubMed ID: 4463294
    [No Abstract]   [Full Text] [Related]  

  • 5. Masugi nephritis: the renal lesion and the coagulation processes.
    Borrero J; Todd ME; Becker CG; Becker EL
    Clin Nephrol; 1972; 1(2):86-93. PubMed ID: 4669792
    [No Abstract]   [Full Text] [Related]  

  • 6. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
    Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
    J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antinephritic effect of MD-805 [(2R, 4R) -4-methyl-[N2-(3-methyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl) -L-arginyl] -2-piperidine-carboxylic acid monohydrate], a new antithrombin agent, on crescentic-type anti-GMB nephritis in rats].
    Suzuki Y; Yamada H; Ito M
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):463-73. PubMed ID: 6471586
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporin A and anti-glomerular basement membrane antibody glomerulonephritis in rats.
    Wood A; Adu D; Birtwistle RJ; Brewer DB; Michael J
    Br J Exp Pathol; 1988 Apr; 69(2):189-95. PubMed ID: 3259890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butein ameliorates experimental anti-glomerular basement membrane (GBM) antibody-associated glomerulonephritis in rats (1).
    Hayashi K; Nagamatsu T; Honda S; Suzuki Y
    Jpn J Pharmacol; 1996 Jan; 70(1):55-64. PubMed ID: 8822089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit.
    Holdsworth SR; Tipping PG
    J Clin Invest; 1985 Oct; 76(4):1367-74. PubMed ID: 4056035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the origin of urinary fibrin-fibrinogen-related antigen in glomerulonephritis.
    Bone JM; Sherman LA; Valdes AJ; Lubowitz H
    J Lab Clin Med; 1977 May; 89(5):1043-52. PubMed ID: 558266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Existence of glomerulus-bound anti-renal basement membrane IgG in human chronic glomerulonephritic kidneys].
    Masugi Y; Sugisaki Y; Hatanaka Y; Oami H
    Nihon Jinzo Gakkai Shi; 1972 Sep; 14(3):341-55. PubMed ID: 4565169
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic effects of leflunomide, a new antirheumatic drug, on glomerulonephritis induced by the antibasement membrane antibody in rats.
    Ogawa T; Inazu M; Gotoh K; Inoue T; Hayashi S
    Clin Immunol Immunopathol; 1991 Oct; 61(1):103-18. PubMed ID: 1959237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative evaluation of anticoagulants in experimental nephrotoxic nephritis.
    Thomson NM; Simpson IJ; Peters DK
    Clin Exp Immunol; 1975 Feb; 19(2):301-8. PubMed ID: 1212801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue plasminogen activator therapy of rabbit nephrotoxic nephritis.
    Zoja C; Corna D; Macconi D; Zilio P; Bertani T; Remuzzi G
    Lab Invest; 1990 Jan; 62(1):34-40. PubMed ID: 1688634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubulointerstitial nephritis and glomerulonephritis in Brown-Norway rats immunized with heterologous glomerular basement membrane.
    Robertson JL; Hill GS; Rowlands DT
    Am J Pathol; 1977 Jul; 88(1):53-68. PubMed ID: 879271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of protein excretion by dimethyl sulfoxide in rats with passive Heymann nephritis.
    Lotan D; Kaplan BS; Fong JS; Goodyer PR; de Chadarevian JP
    Kidney Int; 1984 May; 25(5):778-88. PubMed ID: 6471664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular fibrinolytic activity during nephrotoxic nephritis.
    Giroux L; Verroust P; Morel-Maroger L; Delarue F; Delauche M; Sraer JD
    Lab Invest; 1979 Apr; 40(4):415-22. PubMed ID: 431041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A scanning electron microscopic study of crescentic Masugi nephritis in the rabbit.
    Kondo Y; Kubosawa H; Akikusa B; Sugano I
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 50(4):345-53. PubMed ID: 2870585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of membranous nephropathy into anti-glomerular-basement-membrane glomerulonephritis.
    Klassen J; Elwood C; Grossberg AL; Milgrom F; Montes M; Sepulveda M; Andres GA
    N Engl J Med; 1974 Jun; 290(24):1340-4. PubMed ID: 4275110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.